Aobiome LLC
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2013-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.aobiome.com
Clinical Trials
11
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (11 trials with phase data)• Click on a phase to view related trials
B244 Topical Spray for the Treatment of Pruritus in Adults With a History of Atopic Dermatitis
- First Posted Date
- 2020-07-28
- Last Posted Date
- 2025-01-28
- Lead Sponsor
- AOBiome LLC
- Target Recruit Count
- 547
- Registration Number
- NCT04490109
- Locations
- 🇺🇸
Palm Beach Dermatology Group, Delray Beach, Florida, United States
🇺🇸Medical Dermatology Associates of Chicago, Chicago, Illinois, United States
🇺🇸Clinical Investigation Specialists, Libertyville, Illinois, United States
A Study of B244 Delivered as a Topical Spray to Assess Safety in Pediatric Subjects With Atopic Dermatitis
- Conditions
- EczemaAtopic Dermatitis
- First Posted Date
- 2018-12-14
- Last Posted Date
- 2024-08-05
- Lead Sponsor
- AOBiome LLC
- Target Recruit Count
- 28
- Registration Number
- NCT03775434
- Locations
- 🇺🇸
Dermatology Trial Associates, Bryant, Arkansas, United States
🇺🇸L.A. Universal Research Center, Inc., Los Angeles, California, United States
🇺🇸The Indiana Clinical Trials Center, Plainfield, Indiana, United States
A Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Rosacea
- Conditions
- Rosacea
- First Posted Date
- 2018-07-18
- Last Posted Date
- 2022-09-16
- Lead Sponsor
- AOBiome LLC
- Target Recruit Count
- 140
- Registration Number
- NCT03590366
- Locations
- 🇺🇸
Tampa Bay Medical Research, Clearwater, Florida, United States
🇺🇸Veritas Research Corp, Miami, Florida, United States
🇺🇸South Coast Research Center, Inc., Miami, Florida, United States
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
- Conditions
- Migraine
- First Posted Date
- 2018-04-05
- Last Posted Date
- 2022-10-04
- Lead Sponsor
- AOBiome LLC
- Target Recruit Count
- 313
- Registration Number
- NCT03488563
- Locations
- 🇺🇸
Baptist Health Center for Clinical Research, Little Rock, Arkansas, United States
🇺🇸Collaborative Neuroscience Network, LLC, Long Beach, California, United States
🇺🇸CI Trials, Riverside, California, United States
Study to Assess the Safety, Tolerability, and Preliminary Efficacy of B244 in Healthy Volunteers and Subjects With Seasonal Allergic Rhinitis
- Conditions
- Healthy VolunteersAllergic RhinitisAllergic Rhinitis Due to Grass Pollen
- First Posted Date
- 2017-09-21
- Last Posted Date
- 2022-11-25
- Lead Sponsor
- AOBiome LLC
- Target Recruit Count
- 71
- Registration Number
- NCT03290248
- Locations
- 🇺🇸
Orange County Research Center, Tustin, California, United States
🇨🇦Inflamax, Mississauga, Ontario, Canada
- Prev
- 1
- 2
- 3
- Next
News
Rosacea Therapeutics Pipeline Shows Promise with Emerging Therapies
Over 25 companies are developing novel rosacea treatments, indicating a robust pipeline.